The initial euphoria over the GLP-1 drugs like Ozempic has mellowed, but catalysts expected in 2025 could energize investor interest in the stocks.
Related Posts
U.S. says it will start revoking visas for Chinese students
The United States will start revoking visas of Chinese students, including those with connections to the Chinese Communist Party or studying in critical fields.
OpenAI considering 16 states for data center campuses as part of Trump’s Stargate project
OpenAI executives updated reporters on Thursday about the level of interest the company is seeing from states interested in building large data centers.
From EVs to beauty: Strategist names four stocks to buy in 2025
There will be “significant opportunities” for stock pickers in 2025, according to Michele Schneider.